Eli Lilly & Co. (LLY)
981.64
-15.95
(-1.60%)
USD |
NYSE |
Dec 09, 16:00
982.50
+0.86
(+0.09%)
After-Hours: 20:00
Eli Lilly Market Cap: 878.59B for Dec. 9, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 168.99B |
| Regeneron Pharmaceuticals, Inc. | 72.79B |
| Adverum Biotechnologies, Inc. | 96.26M |
| Viking Therapeutics, Inc. | 4.212B |
| Moderna, Inc. | 11.05B |
Market Cap Related Metrics
| PE Ratio | 48.55 |
| PS Ratio | 15.06 |
| PEG Ratio | 0.4006 |
| Price to Book Value | 36.93 |
| Price to Free Cash Flow | 139.04 |
| Price | 981.64 |
| Earnings Yield | 2.06% |
| PEGY Ratio | 0.3986 |
| Operating PE Ratio | 33.91 |
| Normalized PE Ratio | 43.48 |